Abstract
The invention relates to integrin binding peptides, pharmaceutical compositions comprising the peptides and to uses thereof as therapeutic, diagnostic, imaging and targeting agents.
Original language | English |
---|---|
Patent number | CA3002956 |
IPC | C07K 14/ 705 A I |
Priority date | 21/10/16 |
Publication status | Published - 27 Apr 2017 |